Synergistic Association between Plasma Aβ1–42 and p-tau in Alzheimer’s Disease but Not in Parkinson’s Disease or Frontotemporal Dementia
出版年份 2021 全文链接
标题
Synergistic Association between Plasma Aβ1–42 and p-tau in Alzheimer’s Disease but Not in Parkinson’s Disease or Frontotemporal Dementia
作者
关键词
-
出版物
ACS Chemical Neuroscience
Volume 12, Issue 8, Pages 1376-1383
出版商
American Chemical Society (ACS)
发表日期
2021-04-14
DOI
10.1021/acschemneuro.1c00010
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Longitudinal Amyloid-β PET in Atypical Alzheimer’s Disease and Frontotemporal Lobar Degeneration
- (2020) Jennifer L. Whitwell et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification
- (2020) Nicolas R. Barthélemy et al. Alzheimers Research & Therapy
- Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration
- (2020) Alberto Benussi et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease
- (2020) Amy F. T. Arnsten et al. Alzheimers & Dementia
- Classifications of Neurodegenerative Disorders Using a Multiplex Blood Biomarkers-Based Machine Learning Model
- (2020) Chin-Hsien Lin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in Cognitively Normal Subjects
- (2019) Lih-Fen Lue et al. Frontiers in Aging Neuroscience
- Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
- (2018) Michelle M. Mielke et al. Alzheimers & Dementia
- The aged rhesus macaque manifests Braak stage III/IV Alzheimer's-like pathology
- (2018) Constantinos D. Paspalas et al. Alzheimers & Dementia
- Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer’s Disease
- (2018) Charlotte E. Teunissen et al. JOURNAL OF ALZHEIMERS DISEASE
- The Relation Between Brain Amyloid Deposition, Cortical Atrophy, and Plasma Biomarkers in Amnesic Mild Cognitive Impairment and Alzheimer’s Disease
- (2018) Ling-Yun Fan et al. Frontiers in Aging Neuroscience
- Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia
- (2018) Miguel A. Santos-Santos et al. JAMA Neurology
- A clinicopathological approach to the diagnosis of dementia
- (2017) Fanny M. Elahi et al. Nature Reviews Neurology
- Clinical marker for Alzheimer disease pathology in logopenic primary progressive aphasia
- (2017) Lucia A.A. Giannini et al. NEUROLOGY
- Plasma Tau Levels in Cognitively Normal Middle-Aged and Older Adults
- (2017) Ming-Jang Chiu et al. Frontiers in Aging Neuroscience
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles
- (2016) Shieh-Yueh Yang et al. JOURNAL OF NANOBIOTECHNOLOGY
- The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer’s disease
- (2015) Kiwamu Watanabe et al. Molecular Brain
- Plasma Aβ but Not Tau is Related to Brain PiB Retention in Early Alzheimer’s Disease
- (2014) Kai-Yuan Tzen et al. ACS Chemical Neuroscience
- Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine
- (2014) David J. Irwin et al. ACTA NEUROPATHOLOGICA
- Instrumental activities of daily living are impaired in Parkinson’s disease patients with mild cognitive impairment.
- (2014) Eva Pirogovsky et al. NEUROPSYCHOLOGY
- Combined Plasma Biomarkers for Diagnosing Mild Cognition Impairment and Alzheimer’s Disease
- (2013) Ming-Jang Chiu et al. ACS Chemical Neuroscience
- Plasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early alzheimer's disease
- (2013) Ming-Jang Chiu et al. HUMAN BRAIN MAPPING
- New Assay for Old Markers-Plasma Beta Amyloid of Mild Cognitive Impairment and Alzheimer's Disease
- (2012) M.J. Chiu et al. Current Alzheimer Research
- Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
- (2012) Irene Litvan et al. MOVEMENT DISORDERS
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
- (2011) Katya Rascovsky et al. BRAIN
- Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
- (2011) Heiko Braak et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Classification of primary progressive aphasia and its variants
- (2011) M. L. Gorno-Tempini et al. NEUROLOGY
- Pathological correlates of frontotemporal lobar degeneration in the elderly
- (2010) Atik Baborie et al. ACTA NEUROPATHOLOGICA
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
- (2010) Christopher C. Rowe et al. NEUROBIOLOGY OF AGING
- Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update
- (2009) Ian R. A. Mackenzie et al. ACTA NEUROPATHOLOGICA
- The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease
- (2007) Lidia Glodzik-Sobanska et al. NEUROBIOLOGY OF AGING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started